ECCEO 9-IOF | ATHENS | GREECE | March 18 - 21, 2009 | Megaron Athens International Conference Centre

SATURDAY MARCH 21

09.30 - 11.50	SCIENTIFIC SESSION V
	Chairs: René Rizzoli & Sharmila Majumdar
09.30 - 10.00	Plenary lecture 7
	*Debate: long-term treatment of osteoporosis with bisphosphonates: good*
	Speaker: John Bilezikian

10.00 - 10.30	Plenary lecture 8
	*Debate: long-term treatment of osteoporosis with bisphosphonates: bad*
	Speaker: Socrates Papapoulos
10.30 - 10.50	Debate
	Moderator: Eugene McCloskey
10.30 - 11.50	Oral communications selected from abstracts
12.15 - 13.45	Lunch Symposium	Satellite Symposium
	RANKL inhibition as a targeted approach in the management of osteoporosis	*Misconceptions regarding the use of HRT in osteoporosis*
	Sponsored by AMGEN AUDITORIUM 1 - TRIANTI HALL	Organized by the INTERNATIONAL MENOPAUSE SOCIETY AUDITORIUM 2 - SKALKOTAS HALL
	Chair: J.-Y. REGINSTER	Introduction T. DE VILLERS
	Optimizing osteoporosis therapy to address patient needs C. COOPER	PREVENTION vs. treatment - is the FRAX^® model applicable? P. HADJI
	Treatment of postmenopausal bone loss with RANKL inhibition; the STAND and DECIDE study S.E. PAPAPOULOS	Mechanism of action of estrogen on bone: evidence proving fracture protection qualities of estrogen M. BRINCAT
	Fracture protection with RANK Ligand inhibition in patients with post-menopausal osteoporosis C. ROUX	Comparaison of the anti-fracture efficacy and side-effects of estrogen with other agents M. GAMBACCIANI
		The role of HRT in osteoporosis (indication of dose method of delivery and duration of treatment) T. DE VILLIERS
		Q & A
13.45 - 15.00	Poster Session & Exhibition Viewing
14.00 - 15.00	MEET-THE-PROFESSOR SESSIONS - Amgen	14.00 - 15.30 ESCEO
	Muscles and bones - Dieter Felsenberg	*Management of hip fracture*
	Diagnosis and management of hyperparathyroidism - John Bilezikian	Chairs: R. Rizzoli & S. Boonen
	Use and misuse of MRI in the diagnosis and management of ostheoarthritis - Jean-Pierre Pelletier	Welcome and introduction - J.-Y. REGINSTER
		Nutritional aspects in the management of hip fracture - R. RIZZOLI
		Post operative care in hip fracture - K. AKESSON
		Treatment of post menopausal osteoporosis: before and after hip fracture - S. BOONEN
		Rehabilitation after hip fracture - H. MINNE
		Roundtable Discussion leaders: C. ROUX, S. SILVERMAN Participants: E. ABADIE, M.-L. BRANDI, O. BRUYERE, J.-M. KAUFMAN, G. LYRITIS
		Conclusions R. RIZZOLI


15.00 - 18.00	Meeting of the Greek National Scientific Societies
15.00 - 16.30	Management of osteoarthritis
	Supported by an unrestricted educational grant from FARAN Under the auspices of the Hellenic Society for Rheumatology Chairs: Dimitris Karras & George Vaiopoulos
	*Structure modification in osteoarthritis: where are we today?* - Jean-Pierre Pelletier Epidemiology and burden of osteoarthritis in Greece - Styros Aslanidis Practice guidelines in osteoarthritis: a critical review of the role of glucosamine sulfate - Lucio Rovati Roundtable
16.30 - 18.00	Management of osteoporosis
	Supported by an unrestricted educational grant from Servier Hellas Under the auspices of the Hellenic Foundation of Osteoporosis (HELIOS)
	Chairs: George Lyritis & George Trovas
	The National Primary Care plan for a metabolic bone disease network of outpatient clinics - George Lyritis Mediterranean diet and bone health - Meropi Kontoyanni Prevention of bone disease in patients with thyroid dysfunction - S. Tournis Management of the post-fracture disease - Theophilos Karachalios